Allergic diseases (also known as allergic diseases) are considered by the World Health Organization (WHO) to be a major worldwide health problem today. The main allergic diseases include: allergic rhinitis (allergic rhinitis), sinusitis, nasal polyps, bronchial asthma, allergic bronchitis, allergic dermatitis, urticaria, allergic gastroenteritis and allergic conjunctivitis. Allergic reactive diseases are a global health problem that is common worldwide, with a global prevalence of 20-40%, and the number of sufferers is increasing. Allergic rhinitis is a global health problem that is common worldwide, with a global prevalence of 10-25%, and the number of people affected is increasing. The estimated global prevalence of allergic rhinitis in the pediatric population is 20%. Although allergic rhinitis is not a serious disease, it can interfere with daily life, school, and productivity, and can be financially burdensome. Asthma and rhinitis often coexist, supporting the concept of “one airway, one disease”. The management of allergic rhinitis and its impact on asthma WHO 2001. A set of statistics in the United States: 20% of Americans suffer from allergic diseases. Allergic diseases are the sixth leading cause of chronic disease. 35.9 million people suffer from seasonal allergic rhinitis. There are 8 million outpatients with allergic rhinitis each year. 90% of seasonal allergic rhinitis is effective with immunotherapy and 70-80% of perennial allergic rhinitis is effective. In the United States, the total cost of treating allergic rhinitis in 1993 was $340 million, of which $230 million was for drugs and $110 million for physician care. Allergic dermatitis is the most common skin disease in children under 11 years of age, and the number of children diagnosed with allergic skin disease has increased from 3% in 1960 to 10% in 1990.